{
  "patent_number": "US 20250244311",
  "country": "US",
  "title": "How to Pick the Best Cancer Proteins for a Vaccine",
  "original_title": "Methods for predicting the usefulness of proteins or protein fragments for immunotherapy",
  "summary": "This patent describes a method for choosing specific proteins from diseased cells, like cancer cells, to create personalized vaccines by checking if the body already reacts to them or if they bind to certain cell components.",
  "what_it_does": "The patent describes a method for making vaccines, especially for personalized cancer treatment. It involves identifying specific proteins or protein pieces from diseased cells that would be useful for immunotherapy. This identification step, as per claim 20, checks for one or more of three things: (a) if the body already has antibodies against these proteins, (b) if these proteins bind to a cell structure called F-actin, or (c) if they bind to RNA. If any of these conditions are met, it suggests the protein or its genetic code is a good candidate for a vaccine. The method then involves manufacturing a vaccine containing these selected proteins or their genetic instructions. For example, if a patient's tumor cells express a unique protein that the patient's immune system has already started to make antibodies against, that protein would be selected for inclusion in a personalized vaccine (claim 20a).",
  "what_it_does_not_cover": [
    "Does not cover selecting vaccine components solely based on their presence in diseased cells without checking for antibody response, F-actin binding, or RNA binding.",
    "Does not cover methods for making vaccines that do not involve determining these specific binding or response properties of the proteins.",
    "Does not cover vaccines made from proteins that are not expressed by diseased cells, as specified in claim 20.",
    "Does not cover general vaccine manufacturing processes that do not incorporate this specific protein selection methodology.",
    "Does not cover immunotherapy approaches that do not involve a vaccine, such as direct antibody infusions or CAR-T cell therapy."
  ],
  "filed": "2024-10-18",
  "granted": null,
  "expires": "2044-10-18",
  "status": "active",
  "holder": "UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG -UNIVERSITÄT MAINZ",
  "holder_url": "https://patentbrief.org/company/universittsmedizin-der-johannes-gutenberg--universitt-mainz",
  "inventors": [
    {
      "name": "Ugur Sahin",
      "url": "https://patentbrief.org/inventor/ugur-sahin"
    },
    {
      "name": "Mathias Vormehr",
      "url": "https://patentbrief.org/inventor/mathias-vormehr"
    },
    {
      "name": "Martin Löwer",
      "url": "https://patentbrief.org/inventor/martin-lwer"
    },
    {
      "name": "Barbara Schrörs",
      "url": "https://patentbrief.org/inventor/barbara-schrrs"
    },
    {
      "name": "Sebastian Boegel",
      "url": "https://patentbrief.org/inventor/sebastian-boegel"
    }
  ],
  "times_cited": 0,
  "tags": [
    "biotech",
    "pharmaceutical",
    "oncology",
    "immunotherapy",
    "personalized_medicine"
  ],
  "abstract": "The present invention relates to methods for predicting peptides or polypeptides such as T cell epitopes useful for immunotherapy such as for vaccination. In particular, the present invention relates to methods for predicting whether peptides or polypeptides such as tumor-associated antigens or epitopes, in particular tumor-associated neoantigens or neoepitopes, are immunogenic and, in particular, useful for immunotherapy such as for vaccination. The methods of the invention may be used, in particular, for the provision of vaccines which are specific for a patient's tumor and, thus, in the context of personalized cancer vaccines.",
  "url": "https://patentbrief.org/patent/us/20250244311/methods-for-predicting-the-usefulness-of-proteins-or-protein-fragments-for-immun",
  "markdown_url": "https://patentbrief.org/patent/us/20250244311/methods-for-predicting-the-usefulness-of-proteins-or-protein-fragments-for-immun/md",
  "google_patents_url": "https://patents.google.com/patent/US20250244311",
  "relatedPatents": [
    {
      "patentNumber": "10377797",
      "countryCode": "US",
      "title": "Training Immune Cells to Fight Cancer Using Specific Markers",
      "url": "https://patentbrief.org/patent/us/10377797/cell-epitopes-and-combination-of-cell-epitopes-for-use-in-the-immunotherapy-of-m"
    },
    {
      "patentNumber": "10314897",
      "countryCode": "US",
      "title": "How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer",
      "url": "https://patentbrief.org/patent/us/10314897/peptides-and-combination-of-peptides-for-use-in-immunotherapy-against-various-ca"
    },
    {
      "patentNumber": "12734225",
      "countryCode": "US",
      "title": "New Peptide Vaccines for Fighting Cancer",
      "url": "https://patentbrief.org/patent/us/12734225/fusion-peptide-vaccines"
    },
    {
      "patentNumber": "12006349",
      "countryCode": "US",
      "title": "How a Specific Peptide Can Train Your Immune System to Fight Cancer",
      "url": "https://patentbrief.org/patent/us/12006349/peptides-and-combination-of-peptides-for-use-in-immunotherapy-against-various-tu-12006349"
    },
    {
      "patentNumber": "11401319",
      "countryCode": "US",
      "title": "Training Immune Cells to Fight Specific Cancers",
      "url": "https://patentbrief.org/patent/us/11401319/peptides-and-combination-of-peptides-for-use-in-immunotherapy-against-esophageal-11401319"
    }
  ]
}